Biswajit Das

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Cancer Stem Cells

Fluorescent Probe

Histone Deacetylase

Top Venues

Nanomedicine (London, England)

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Somya Ranjan Dash, Biswajit Das, Chinmay Das, Saptarshi Sinha, Subarno Paul, Rajalaxmi Pradhan, Chanakya Nath Kundu
Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β. Nanomedicine (London, England) (2023)